Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: Comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A

Infection and Immunity

Volumn 69, Issue 6, 2001, Pages 4141-4145

  Muller Alouf H ^a   Proft, T ^a   Zollner, T M ^a   Gerlach, D ^a   Champagne, E ^a   Desreumaux, P ^a   Fitting, C ^a   Geoffroy Fauvet, C ^a   Alouf, J E ^a   Cavaillon, J M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; DNA; EXOTOXIN; RNA; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEVER; GENE SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CYTOKINES; EXOTOXINS; HUMANS; MEMBRANE PROTEINS; PYROGENS; RABBITS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0035011305     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.6.4141-4145.2001     Document Type: Article

References (50)

1. Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease
2. Superantigenic Streptococcus pyogenes erythrogenic/pyrogenic exotoxins
3. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two superantigens from Streptococcus pyogenes
4. Western blotting: Electrophoretic transfer of proteins from SDS polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
5. Polymyxin B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin
6. Cytokines in streptococcal infections
7. An alternative method for T-cell receptor repertoire analysis: Clustering of human V-beta subfamilies selected in response to staphylococcal enterotoxins B and E
8. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production
9. Identification of a new extracellular superantigenic mitogen from group A Streptococci
10. Purification and characterisation of Streptococcus pyogenes erythrogenic toxin type A produced by a cloned gene in Streptococcus sanguis
11. Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O
12. Superantigen associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β
13. Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis
14. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis
15. Purification and characterization of erythrogenic toxins. II. In vivo biological activities of erythrogenic toxin produced by Streptococcus pyogenes strain NY-5
16. Tumor necrosis factor production by human T cells stimulated with bacterial superantigens
17. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor
18. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes
19. Responsiveness of peripheral blood mononuclear cells from normal and atopic donors to microbial superantigens
20. Superantigens in human diseases
21. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutanous lymphocyte-associated antigen via stimulation of IL-12
22. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
23. Kawasaki syndrome: Immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin
24. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and non-septic origin
25. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C
26. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide
27. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens
28. Streptococcal pyrogenic exotoxin A (SPEA) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells
29. Streptococcal pyrogenic exotoxin A, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections
30. Dysregulation of in vitro cytokine production by monocytes during sepsis
31. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression
32. T cell activation and cytokine release in streptococcal toxic shock syndrome
33. Streptococcal superantigens and their role in the pathogenesis of severe infections
34. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
35. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates
36. Correlation between serum TNF alpha and IL-6 levels and severity of group A streptococcal infections
37. Structural basis for recognition of superantigen streptococcal pyrogenic exotoxin A (SPEA1) by MHC class II molecules and T cell receptors
38. Identification and characterization of novel superantigens from Streptococcus pyogenes
39. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure and significant antigenic variation
40. Erythrogenic toxins A, B and C: Occurrence of genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome
41. Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation
42. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFNγ
43. Detection of bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic shock syndrome
44. Severe group A streptococci associated with toxic shock like syndrome and scarlet fever toxin A
45. Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein
46. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B and C
47. Bacterial superantigens - Mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases
48. Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins
49. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes
50. Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytes